To include your compound in the COVID-19 Resource Center, submit it here.

Periostat doxycycline: Phase II; Phase III to treat rosacea; marketed to treat periodontal disease

In a placebo-controlled Phase II study in 50 patients, Periostat significantly lowered inflammatory marker CRP

Read the full 155 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE